ZA969622B
(en)
*
|
1995-12-13 |
1998-05-15 |
Upjohn Co |
Oxazolidinone antibacterial agents having a six-membered heteroaromatic ring.
|
GB9609919D0
(en)
|
1996-05-11 |
1996-07-17 |
Zeneca Ltd |
Chemical compounds
|
GB9717807D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
GB9725244D0
(en)
|
1997-11-29 |
1998-01-28 |
Zeneca Ltd |
Chemical compounds
|
US7002020B1
(en)
|
1998-01-23 |
2006-02-21 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
CA2318969A1
(en)
*
|
1998-01-23 |
1999-07-29 |
Mikhail F. Gordeev |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
US6562844B2
(en)
|
1998-01-23 |
2003-05-13 |
Pharmacia & Upjohn Company |
Oxazolidinone combinatorial libraries, compositions and methods of preparation
|
GB9928568D0
(en)
|
1999-12-03 |
2000-02-02 |
Zeneca Ltd |
Chemical compounds
|
DE19962924A1
(en)
|
1999-12-24 |
2001-07-05 |
Bayer Ag |
Substituted oxazolidinones and their use
|
GB0009803D0
(en)
|
2000-04-25 |
2000-06-07 |
Astrazeneca Ab |
Chemical compounds
|
JP2004504321A
(en)
|
2000-07-17 |
2004-02-12 |
ランバクシー ラボラトリーズ リミテッド |
Oxazolidinone derivatives as antimicrobial agents
|
WO2003008389A1
(en)
*
|
2001-07-16 |
2003-01-30 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as potential antimicrobials
|
DE10129725A1
(en)
|
2001-06-20 |
2003-01-02 |
Bayer Ag |
Combination therapy of substituted oxazolidinones
|
US6956040B2
(en)
|
2001-07-16 |
2005-10-18 |
Ranbaxy Laboratories Limited |
Oxazolidinone piperazinyl derivatives as potential antimicrobials
|
JP2005507386A
(en)
|
2001-09-11 |
2005-03-17 |
アストラゼネカ アクチボラグ |
Oxazolidinones and / or isoxazolines as antibacterial agents
|
WO2003035073A1
(en)
|
2001-10-25 |
2003-05-01 |
Astrazeneca Ab |
Isoxazoline derivatives useful as antimicrobials
|
RU2004129276A
(en)
|
2002-02-28 |
2005-06-10 |
Астразенека Аб (Se) |
3-CYCLIC-5- (NITROGEN-CONTAINING 5-MEMBER RING) METHYL-OXAZOLIDININE DERIVATIVES AND THEIR APPLICATION AS ANTIBACTERIAL MEANS
|
EP1480975A2
(en)
|
2002-02-28 |
2004-12-01 |
Astrazeneca AB |
Chemical compounds
|
WO2003093247A2
(en)
*
|
2002-04-30 |
2003-11-13 |
Orchid Chemicals & Pharmaceuticals Ltd |
Antibacterial agents
|
AU2002339721A1
(en)
|
2002-09-20 |
2004-04-08 |
Lupin Limited |
Oxazolidinone derivatives, process for their preperation and their use as antimycobacterial agents
|
DE10300111A1
(en)
|
2003-01-07 |
2004-07-15 |
Bayer Healthcare Ag |
Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide
|
DE10355461A1
(en)
|
2003-11-27 |
2005-06-23 |
Bayer Healthcare Ag |
Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases
|
WO2005082899A1
(en)
*
|
2004-01-28 |
2005-09-09 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
US20050203102A1
(en)
*
|
2004-03-09 |
2005-09-15 |
Orchid Chemicals & Pharmaceuticals Ltd. |
antibacterial agents
|
AR051092A1
(en)
|
2004-09-20 |
2006-12-20 |
Xenon Pharmaceuticals Inc |
HETEROCICLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF ESTEAROIL-COA
|
CN101083982A
(en)
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
|
AR051091A1
(en)
|
2004-09-20 |
2006-12-20 |
Xenon Pharmaceuticals Inc |
HETEROCICLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF ESTEAROIL-COA DESATURASA
|
WO2006034279A1
(en)
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as therapeutic agents
|
EP2269610A3
(en)
|
2004-09-20 |
2011-03-09 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
CN101083992A
(en)
*
|
2004-09-20 |
2007-12-05 |
泽农医药公司 |
Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
|
US8071603B2
(en)
|
2004-09-20 |
2011-12-06 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
|
WO2006043121A1
(en)
*
|
2004-10-20 |
2006-04-27 |
Ranbaxy Laboratories Limited |
Oxazolidinone derivatives as antimicrobials
|
EP1685841A1
(en)
|
2005-01-31 |
2006-08-02 |
Bayer Health Care Aktiengesellschaft |
Prevention and treatment of thromboembolic disorders
|
GT200600046A
(en)
*
|
2005-02-09 |
2006-09-25 |
|
COMBINATION THERAPY
|
US8541457B2
(en)
|
2005-06-03 |
2013-09-24 |
Xenon Pharmaceuticals Inc. |
Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
|
DE102005045518A1
(en)
|
2005-09-23 |
2007-03-29 |
Bayer Healthcare Ag |
New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa
|
DE102005047561A1
(en)
|
2005-10-04 |
2007-04-05 |
Bayer Healthcare Ag |
Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance
|
WO2007039132A1
(en)
|
2005-10-04 |
2007-04-12 |
Bayer Healthcare Ag |
Novel polymorphous form and the amorphous form of 5-chloro-n-({ (5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
|
WO2007114326A1
(en)
*
|
2006-03-31 |
2007-10-11 |
Research Foundation Itsuu Laboratory |
Novel compound having heterocyclic ring
|
DE102007018662A1
(en)
|
2007-04-20 |
2008-10-23 |
Bayer Healthcare Ag |
Oxazolidinone for the treatment and prophylaxis of pulmonary hypertension
|
DE102007028318A1
(en)
|
2007-06-20 |
2008-12-24 |
Bayer Healthcare Ag |
Oxazolidinone for the treatment and prophylaxis of sepsis
|
EP2138178A1
(en)
|
2008-06-28 |
2009-12-30 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidninones for the treatment fo chronic obstructive pulmonary disease (COPD) and/or asthma
|
EP2140866A1
(en)
|
2008-07-04 |
2010-01-06 |
Bayer Schering Pharma Aktiengesellschaft |
Oxazolidinones for the treatment of inflammatory conditions of the gastrointestinal tract
|
WO2023061617A1
(en)
*
|
2020-12-21 |
2023-04-20 |
F. Hoffmann-La Roche Ag |
Sulfonylpiperazinyl compounds for treatment of bacterial infections
|